Goadsby PJ - Search Results

1

Trial of Galcanezumab in Prevention of Episodic Cluster Headache.

Goadsby PJ, Dodick DW, Leone M, Bardos JN, Oakes TM, Millen BA, Zhou C, Dowsett SA, Aurora SK, Ahn AH, Yang JY, Conley RR, Martinez JM. Goadsby PJ, et al. N Engl J Med. 2019 Jul 11;381(2):132-141. doi: 10.1056/NEJMoa1813440. N Engl J Med. 2019. PMID: 31291515 Clinical Trial.

2

Oral zolmitriptan is effective in the acute treatment of cluster headache.

Bahra A, Gawel MJ, Hardebo JE, Millson D, Breen SA, Goadsby PJ. Bahra A, et al. Among authors: goadsby pj. Neurology. 2000 May 9;54(9):1832-9. doi: 10.1212/wnl.54.9.1832. Neurology. 2000. PMID: 10802793 Clinical Trial.

3

PET and MRA findings in cluster headache and MRA in experimental pain.

May A, Bahra A, Büchel C, Frackowiak RS, Goadsby PJ. May A, et al. Among authors: goadsby pj. Neurology. 2000 Nov 14;55(9):1328-35. doi: 10.1212/wnl.55.9.1328. Neurology. 2000. PMID: 11087776

4

Cluster headache.

Dodick DW, Rozen TD, Goadsby PJ, Silberstein SD. Dodick DW, et al. Among authors: goadsby pj. Cephalalgia. 2000 Nov;20(9):787-803. doi: 10.1046/j.1468-2982.2000.00118.x. Cephalalgia. 2000. PMID: 11167909 Review.

5

Intranasal sumatriptan in cluster headache: randomized placebo-controlled double-blind study.

van Vliet JA, Bahra A, Martin V, Ramadan N, Aurora SK, Mathew NT, Ferrari MD, Goadsby PJ. van Vliet JA, et al. Among authors: goadsby pj. Neurology. 2003 Feb 25;60(4):630-3. doi: 10.1212/01.wnl.0000046589.45855.30. Neurology. 2003. PMID: 12601104 Clinical Trial.

6

Consensus statement: cardiovascular safety profile of triptans (5-HT agonists) in the acute treatment of migraine.

Dodick D, Lipton RB, Martin V, Papademetriou V, Rosamond W, MaassenVanDenBrink A, Loutfi H, Welch KM, Goadsby PJ, Hahn S, Hutchinson S, Matchar D, Silberstein S, Smith TR, Purdy RA, Saiers J; Triptan Cardiovascular Safety Expert Panel. Dodick D, et al. Among authors: goadsby pj. Headache. 2004 May;44(5):414-25. doi: 10.1111/j.1526-4610.2004.04078.x. Headache. 2004. PMID: 15147249 Review.

7

TRIPSTAR: prioritizing oral triptan treatment attributes in migraine management.

Goadsby PJ, Dodick DW, Ferrari MD, McCrory DC, Williams P. Goadsby PJ, et al. Acta Neurol Scand. 2004 Sep;110(3):137-43. doi: 10.1111/j.1600-0404.2004.00310.x. Acta Neurol Scand. 2004. PMID: 15285768

8

Deep brain stimulation for intractable chronic cluster headache: proposals for patient selection.

Leone M, May A, Franzini A, Broggi G, Dodick D, Rapoport A, Goadsby PJ, Schoenen J, Bonavita V, Bussone G. Leone M, et al. Among authors: goadsby pj. Cephalalgia. 2004 Nov;24(11):934-7. doi: 10.1111/j.1468-2982.2004.00742.x. Cephalalgia. 2004. PMID: 15482354

9

Prioritizing treatment attributes and their impact on selecting an oral triptan: results from the TRIPSTAR Project.

Dodick DW, Lipton RB, Ferrari MD, Goadsby PJ, McCrory D, Cutrer FM, Williams P. Dodick DW, et al. Among authors: goadsby pj. Curr Pain Headache Rep. 2004 Dec;8(6):435-42. doi: 10.1007/s11916-004-0064-2. Curr Pain Headache Rep. 2004. PMID: 15509456 Review.

10

Priorities for triptan treatment attributes and the implications for selecting an oral triptan for acute migraine: a study of US primary care physicians (the TRIPSTAR Project).

Cutrer FM, Goadsby PJ, Ferrari MD, Lipton RB, Dodick DW, McCrory D, Williams P. Cutrer FM, et al. Among authors: goadsby pj. Clin Ther. 2004 Sep;26(9):1533-45. doi: 10.1016/j.clinthera.2004.09.011. Clin Ther. 2004. PMID: 15531016

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

876 results

Search Page

Filters